Published in Endocr J on February 17, 2010
Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol (2012) 4.86
Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)? Pharmacol Rev (2011) 1.85
Sirtuin-1 regulation of mammalian metabolism. Trends Mol Med (2011) 1.07
The ways and means that fine tune Sirt1 activity. Trends Biochem Sci (2013) 1.07
IL-15 overexpression promotes endurance, oxidative energy metabolism, and muscle PPARδ, SIRT1, PGC-1α, and PGC-1β expression in male mice. Endocrinology (2012) 0.95
Mitochondrial sirtuins and metabolic homeostasis. Best Pract Res Clin Endocrinol Metab (2012) 0.92
Interferon gamma (IFN-γ) disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcription. Nucleic Acids Res (2011) 0.92
Sirtuins and pyridine nucleotides. Circ Res (2012) 0.86
AMPK-Dependent Metabolic Regulation by PPAR Agonists. PPAR Res (2010) 0.85
Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function. Nucl Recept Signal (2015) 0.84
Regulation of Nox enzymes expression in vascular pathophysiology: Focusing on transcription factors and epigenetic mechanisms. Redox Biol (2015) 0.83
Stress Inducibility of SIRT1 and Its Role in Cytoprotection and Cancer. Genes Cancer (2013) 0.83
Mitochondrial matrix Ca²⁺ accumulation regulates cytosolic NAD⁺/NADH metabolism, protein acetylation, and sirtuin expression. Mol Cell Biol (2014) 0.83
Ligand-activated peroxisome proliferator-activated receptor-δ and -γ inhibit lipopolysaccharide-primed release of high mobility group box 1 through upregulation of SIRT1. Cell Death Dis (2014) 0.82
IL-15 is required for postexercise induction of the pro-oxidative mediators PPARδ and SIRT1 in male mice. Endocrinology (2013) 0.82
Interferon regulatory factor 9 is critical for neointima formation following vascular injury. Nat Commun (2014) 0.79
Pharmacogenomic characterization of gemcitabine response--a framework for data integration to enable personalized medicine. Pharmacogenet Genomics (2014) 0.77
Sirtuin 1: A Target for Kidney Diseases. Mol Med (2015) 0.77
Caffeic Acid Phenethyl Ester Regulates PPAR's Levels in Stem Cells-Derived Adipocytes. PPAR Res (2016) 0.77
Peroxisome proliferator-activated receptor (PPAR) α and δ activators induce ICAM-1 expression in quiescent non stimulated endothelial cells. J Inflamm (Lond) (2016) 0.75
Characterization of the 5'-flanking region of the human DNA helicase B (HELB) gene and its response to trans-Resveratrol. Sci Rep (2016) 0.75
Perfluorooctanesulfonate Mediates Renal Tubular Cell Apoptosis through PPARgamma Inactivation. PLoS One (2016) 0.75
Role of prostacyclin signaling in endothelial production of soluble amyloid precursor protein-α in cerebral microvessels. J Cereb Blood Flow Metab (2015) 0.75
Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol (2012) 1.95
Phosphorylation and inactivation of myeloid cell leukemia 1 by JNK in response to oxidative stress. J Biol Chem (2002) 1.79
Cisplatin-induced macroautophagy occurs prior to apoptosis in proximal tubules in vivo. Clin Exp Nephrol (2009) 1.74
Erdheim-Chester disease: report of a case with PCR-based analysis of the expression of osteopontin and survivin in Xanthogranulomas following glucocorticoid treatment. Endocr J (2008) 1.64
Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic Lupus erythematosus. Arthritis Rheumatol (2014) 1.61
GABA release from proopiomelanocortin neurons. J Neurosci (2004) 1.53
Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues. Proc Natl Acad Sci U S A (2005) 1.48
An extra-adrenal abdominal pheochromocytoma causing ectopic ACTH syndrome. Am J Hypertens (2005) 1.42
Hepatic arteriovenous malformation with hyperammonemia in Rendu-Osler-Weber syndrome. J Gastrointestin Liver Dis (2011) 1.40
Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress. Pharmacol Biochem Behav (2002) 1.32
Primary amelanotic malignant melanoma of the female urethra. Int J Urol (2007) 1.32
Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis. Clin Exp Nephrol (2012) 1.28
Wnt4-transformed mouse embryonic stem cells differentiate into renal tubular cells. Biochem Biophys Res Commun (2005) 1.14
Sestrin-2 and BNIP3 regulate autophagy and mitophagy in renal tubular cells in acute kidney injury. Am J Physiol Renal Physiol (2013) 1.11
Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf) (2006) 1.11
Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions. J Lab Clin Med (2005) 1.10
Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes. Metabolism (2004) 1.07
The cyclin-dependent kinase inhibitor p21 is required for TGF-beta1-induced podocyte apoptosis. Kidney Int (2005) 1.07
A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis. J Natl Cancer Inst (2013) 1.04
Sitagliptin, a dipeptidyl peptidase-IV inhibitor, improves psoriasis. Dermatology (2011) 1.00
Both cyclin I and p35 are required for maximal survival benefit of cyclin-dependent kinase 5 in kidney podocytes. Am J Physiol Renal Physiol (2012) 1.00
The C-terminal tail of aquaporin-2 determines apical trafficking. Kidney Int (2005) 1.00
Serum paraoxonase activity decreases in rheumatoid arthritis. Life Sci (2003) 1.00
Dehydroepiandrosterone-sulfate inhibits nuclear factor-kappaB-dependent transcription in hepatocytes, possibly through antioxidant effect. J Clin Endocrinol Metab (2004) 1.00
Intraoperative 3-dimensional imaging-based navigation-assisted anatomic double-bundle anterior cruciate ligament reconstruction. Arthroscopy (2008) 1.00
Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension. Circ Res (2013) 0.99
Pathogenesis of nephrogenic diabetes insipidus by aquaporin-2 C-terminus mutations. Kidney Int (2003) 0.98
Roles of Sp1 and protein kinase C in regulation of human serum paraoxonase 1 (PON1) gene transcription in HepG2 cells. Atherosclerosis (2004) 0.98
The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad. J Am Soc Nephrol (2003) 0.98
PIASy mediates hypoxia-induced SIRT1 transcriptional repression and epithelial-to-mesenchymal transition in ovarian cancer cells. J Cell Sci (2013) 0.98
Detection of autoantibodies against the pituitary-specific proteins in patients with lymphocytic hypophysitis. Eur J Endocrinol (2002) 0.97
Proinflammatory cytokines but not acute phase serum amyloid A or C-reactive protein, downregulate paraoxonase 1 (PON1) expression by HepG2 cells. Amyloid (2002) 0.96
Identification of a functional AP1 element in the rat vasopressin gene promoter. Endocrinology (2006) 0.95
High glucose induces transactivation of the alpha2-HS glycoprotein gene through the ERK1/2 signaling pathway. J Atheroscler Thromb (2009) 0.94
Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription. Endocr J (2010) 0.94
Loss of life after evacuation: lessons learned from the Fukushima accident. Lancet (2012) 0.94
Expression and function of Ets-1 during experimental acute renal failure in rats. J Am Soc Nephrol (2004) 0.93
Serum fetuin-A is an independent marker of insulin resistance in Japanese men. J Atheroscler Thromb (2010) 0.93
Anatomical placement of double femoral tunnels in anterior cruciate ligament reconstruction: anteromedial tunnel first or posterolateral tunnel first? Knee Surg Sports Traumatol Arthrosc (2010) 0.93
Serum level of soluble (pro)renin receptor is modulated in chronic kidney disease. Clin Exp Nephrol (2013) 0.92
Interferon gamma (IFN-γ) disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcription. Nucleic Acids Res (2011) 0.92
Differential effects of forced swim-stress on the corticotropin-releasing hormone and vasopressin gene transcription in the parvocellular division of the paraventricular nucleus of rat hypothalamus. Neurosci Lett (2004) 0.92
Anti-alpha-enolase antibodies in pituitary disease. Endocr J (2003) 0.92
Spontaneous remission of small cell lung cancer: a case report and review in the literature. Lung Cancer (2006) 0.92
[Serum leptin levels in patients with rheumatoid arthritis are correlated with body mass index]. Rinsho Byori (2002) 0.91
Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system. Peptides (2004) 0.91
Positron emission tomography/computed tomography: a clinical tool for evaluation of enthesitis in patients with spondyloarthritides. Rheumatology (Oxford) (2009) 0.91
Smad7 mediates transforming growth factor-beta-induced apoptosis in mesangial cells. Kidney Int (2002) 0.90
Regulation of human glucocorticoid receptor gene transcription by Sp1 and p53. Mol Cell Endocrinol (2004) 0.90
Evidence for megalin-mediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules. Lab Invest (2005) 0.90
High glucose alone, as well as in combination with proinflammatory cytokines, stimulates nuclear factor kappa-B-mediated transcription in hepatocytes in vitro. J Diabetes Complications (2006) 0.90
Muscle strength is a marker of insulin resistance in patients with type 2 diabetes: a pilot study. Endocr J (2007) 0.89
Insulin exhibits short-term anti-inflammatory but long-term proinflammatory effects in vitro. Mol Cell Endocrinol (2008) 0.88
Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion. Hum Genet (2004) 0.88
Glucocorticoid receptor-beta and receptor-gamma exert dominant negative effect on gene repression but not on gene induction. Endocrinology (2010) 0.88
Coexisting primary hyperparathyroidism and sarcoidosis in a patient with severe hypercalcemia. Endocr J (2008) 0.88
Prednisolone markedly reduced serum IgG4 levels along with the improvement of pituitary mass and anterior pituitary function in a patient with IgG4-related infundibulo-hypophysitis. Endocr J (2013) 0.88
Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes. Acta Diabetol (2008) 0.88
Rathke's cleft cyst with short-term size changes in response to glucocorticoid replacement. Endocr J (2008) 0.88
Regulation of glucocorticoid receptor transcription and nuclear translocation during single and repeated immobilization stress. Endocrinology (2010) 0.88
Pitavastatin induces PON1 expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells. Atherosclerosis (2008) 0.88
Airway Scope for emergency intubations: usefulness of a new video-laryngoscope. Hiroshima J Med Sci (2008) 0.87
A promoter polymorphism of the alpha2-HS glycoprotein gene is associated with its transcriptional activity. Diabetes Res Clin Pract (2007) 0.87
Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1beta and tumor necrosis factor-alpha, but is upregulated by interleukin-6. Life Sci (2003) 0.87
Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene. Metabolism (2005) 0.87
Effects of social isolation on mRNA expression for corticotrophin-releasing hormone receptors in prairie voles. Psychoneuroendocrinology (2010) 0.86
Inhibition of 11beta-hydroxysteroid dehydrogenase eliminates impaired glucocorticoid suppression and induces apoptosis in corticotroph tumor cells. Endocrinology (2005) 0.86
Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells. J Endocrinol (2007) 0.86
Immune thrombocytopenic purpura associated with rheumatoid arthritis: case report. Clin Rheumatol (2005) 0.86